Design Therapeutics, Inc. (DSGN) Shareholders’ equity 2020–2025
Design Therapeutics, Inc. (DSGN) shareholders’ equity at each fiscal year-end, per SEC filings.
$212.5MFY2025 · since FY2020: -$11.3M → $212.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $212.5M | -12.2% |
| FY2024 | $242.1M | — |
| FY2020 | -$11.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice